Vanguard Group Inc Rocket Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 6,122,461 shares of RCKT stock, worth $22.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,122,461

Previous 6,617,784 7.48%

Holding current value

$22.7 Million

Previous $44.1 Million 66.02%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$2.33 - $8.01 $1.15 Million - $3.97 Million	-495,323 Reduced 7.48%	6,122,461 $15 Million
Q1 2025 May 09, 2025	BUY	$6.67 - $12.72 $268,060 - $511,204	40,189 Added 0.61%	6,617,784 $44.1 Million
Q4 2024 Feb 11, 2025	BUY	$11.35 - $18.82 $11.8 Million - $19.6 Million	1,040,655 Added 18.79%	6,577,595 $82.7 Million
Q3 2024 Nov 13, 2024	SELL	$17.6 - $25.88 $4.78 Million - $7.03 Million	-271,610 Reduced 4.68%	5,536,940 $102 Million
Q2 2024 Aug 13, 2024	BUY	$20.66 - $26.72 $9.04 Million - $11.7 Million	437,665 Added 8.15%	5,808,550 $125 Million
Q1 2024 May 10, 2024	SELL	$26.16 - $30.74 $2.01 Million - $2.36 Million	-76,680 Reduced 1.41%	5,370,885 $145 Million
Q4 2023 Feb 14, 2024	BUY	$16.78 - $31.94 $14.2 Million - $26.9 Million	843,552 Added 18.32%	5,447,565 $163 Million
Q3 2023 Nov 14, 2023	BUY	$15.07 - $24.05 $61,560 - $98,244	4,085 Added 0.09%	4,604,013 $94.3 Million
Q2 2023 Aug 14, 2023	BUY	$16.59 - $23.6 $1.12 Million - $1.59 Million	67,504 Added 1.49%	4,599,928 $91.4 Million
Q1 2023 May 15, 2023	BUY	$15.79 - $22.6 $5.46 Million - $7.82 Million	345,882 Added 8.26%	4,532,424 $77.6 Million
Q4 2022 Feb 10, 2023	BUY	$15.5 - $22.76 $11.9 Million - $17.5 Million	769,031 Added 22.5%	4,186,542 $81.9 Million
Q3 2022 Nov 14, 2022	BUY	$12.37 - $18.41 $767,187 - $1.14 Million	62,020 Added 1.85%	3,417,511 $54.5 Million
Q2 2022 Aug 12, 2022	BUY	$7.96 - $16.64 $50,394 - $105,347	6,331 Added 0.19%	3,355,491 $46.2 Million
Q1 2022 May 13, 2022	BUY	$13.16 - $23.68 $631,969 - $1.14 Million	48,022 Added 1.45%	3,349,160 $53.1 Million
Q4 2021 Feb 14, 2022	BUY	$21.52 - $36.02 $1.2 Million - $2.01 Million	55,750 Added 1.72%	3,301,138 $72.1 Million
Q3 2021 Nov 12, 2021	BUY	$27.42 - $48.97 $1.03 Million - $1.84 Million	37,623 Added 1.17%	3,245,388 $97 Million
Q2 2021 Aug 13, 2021	BUY	$39.41 - $47.25 $126 Million - $152 Million	3,207,765 New	3,207,765 $142 Million

Others Institutions Holding RCKT

# of Institutions

218

Shares Held

98.3M

Call Options Held

608K

Put Options Held

474K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $280M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Rocket Pharmaceuticals, Inc. Transaction History